A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network-Reference-Cited by-同舟云学术

A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network

Published:2007-04 Issue:3 Volume:33 Page:307-313
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Adams R.,Morgan M.,Mukherjee S.,Brewster A.,Maughan T.,Morrey D.,Havard T.,Lewis W.,Clark G.,Roberts S.,Vachtsevanos L.,Leong J.,Hardwick R.,Carey D.,Crosby T.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference20 articles.

1. One-year survey of carcinoma of the oesophagus and stomach in Wales;Pye;Br J Surg,2001

2. Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival;Walsh;Dis Esophagus,2002

3. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial;MRC;Lancet,2002

4. Preoperative chemotherapy for resectable thoracic esophageal cancer;Malthaner;Cochrane Database Syst Rev,2003

5. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer;Urschel;Am J Surg,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of esophageal cancer survival after neoadjuvant chemoradiotherapy plus surgery versus definitive chemoradiotherapy: A systematic review and meta-analysis;Asian Journal of Surgery;2024-09

2. Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1;Esophagus;2023-03-18

3. Survival and complications after neoadjuvant chemotherapy or chemoradiotherapy for esophageal cancer: a meta-analysis;Future Oncology;2021-06

4. Chemoradiation as a nonsurgical treatment option for early-stage esophageal cancers: a retrospective cohort study;Journal of Thoracic Disease;2021-01

5. An Integrative “Omics” Approach, for Identification of Bona Fides PLK1 Associated Biomarker in Esophageal Adenocarcinoma;Current Cancer Drug Targets;2019-12-20